sMCI | MCI-AD | |
---|---|---|
(n = 17) | (n = 36) | |
Age (years) | 64 (2) | 70 (1)* |
Sex, female | 6 (35 %) | 13 (36 %) |
MMSE (range 0–30)a | 28 (0.6) | 26 (0.4)* |
Aβ42 | 579 (493–814) | 410 (322–507)** |
tau | 274 (212–418) | 739 (463–950)** |
ptau-181 | 47 (40–79) | 90 (65–124)** |
YKL-40 (ng/ml), baseline | 242 (31) | 327 (19)* |
YKL-40 (ng/ml), follow-up | 247 (23) | 363 (22)* |
Annual change, (β(SE)) | 10.2 (6.4) | 10.1 (3.1)‡ |
VILIP-1 (pg/ml), baseline | 136 (25) | 233 (17) ** |
VILIP-1 (pg/ml), follow-up | 167 (20) | 256 (19)** |
Annual change, (β(SE)) | 16.4 (6.1)§ | 12.0 (3.0)‡ |